Lauren A. Havens
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Research Associate III
Also affiliated: University of North Carolina at Chapel Hill (2019); Central Arkansas Veterans Healthcare System (2024–2026)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Lauren A. Havens' research focuses on the impacts of per- and polyfluoroalkyl substances (PFAS) on maternal and infant health. Her work investigates the associations between exposure to individual and mixtures of PFAS during pregnancy and cardiometabolic outcomes in mothers, as well as neurodevelopment and growth in infants. Havens has also explored the use of capillary blood collection devices for monitoring PFAS exposure in specific populations, such as veterans living near potential contamination sources. Her recent publications examine trimester-specific PFAS transfer from mother to fetus and the connection between PFAS exposure during pregnancy and birth outcomes. Havens' research contributes to understanding the health consequences of environmental pollutants.
Metrics
- h-index: 1
- Publications: 8
- Citations: 8
Positions
-
University of Arkansas for Medical Sciences publications 2024–2026ORCID
-
United States Department of Veterans AffairsORCID
-
Research Associate III publications 2024–2026University of Arkansas for Medical Sciences Institution web page
Selected Publications
-
Tracing PFAS Transfer from Mother to the Fetoplacental Unit: Insights from Trimester-Specific Maternal Serum Profiles (2026)
-
PFAS exposures during pregnancy are associated with infant growth and development during the first 2 years of life (2024)
-
PFAS exposure during pregnancy is associated with maternal cardiometabolic and birth outcomes (2024)
-
Pfas Exposure During Pregnancy is Associated with Maternal Cardiometabolic and Birth Outcomes (2024)
Collaboration Network
Top Collaborators
- Pfas Exposure During Pregnancy is Associated with Maternal Cardiometabolic and Birth Outcomes
- PFAS exposure during pregnancy is associated with maternal cardiometabolic and birth outcomes
- PFAS exposures during pregnancy are associated with infant growth and development during the first 2 years of life
- Tracing PFAS Transfer from Mother to the Fetoplacental Unit: Insights from Trimester-Specific Maternal Serum Profiles
- Pfas Exposure During Pregnancy is Associated with Maternal Cardiometabolic and Birth Outcomes
- PFAS exposure during pregnancy is associated with maternal cardiometabolic and birth outcomes
- PFAS exposures during pregnancy are associated with infant growth and development during the first 2 years of life
- Tracing PFAS Transfer from Mother to the Fetoplacental Unit: Insights from Trimester-Specific Maternal Serum Profiles
- Pfas Exposure During Pregnancy is Associated with Maternal Cardiometabolic and Birth Outcomes
- PFAS exposure during pregnancy is associated with maternal cardiometabolic and birth outcomes
- PFAS exposures during pregnancy are associated with infant growth and development during the first 2 years of life
- Pfas Exposure During Pregnancy is Associated with Maternal Cardiometabolic and Birth Outcomes
- PFAS exposure during pregnancy is associated with maternal cardiometabolic and birth outcomes
- PFAS exposures during pregnancy are associated with infant growth and development during the first 2 years of life
- Pfas Exposure During Pregnancy is Associated with Maternal Cardiometabolic and Birth Outcomes
- PFAS exposure during pregnancy is associated with maternal cardiometabolic and birth outcomes
- PFAS exposures during pregnancy are associated with infant growth and development during the first 2 years of life
- PFAS exposure during pregnancy is associated with maternal cardiometabolic and birth outcomes
- PFAS exposures during pregnancy are associated with infant growth and development during the first 2 years of life
- Tracing PFAS Transfer from Mother to the Fetoplacental Unit: Insights from Trimester-Specific Maternal Serum Profiles
- Pfas Exposure During Pregnancy is Associated with Maternal Cardiometabolic and Birth Outcomes
- PFAS exposures during pregnancy are associated with infant growth and development during the first 2 years of life
- PFAS exposure during pregnancy is associated with maternal cardiometabolic and birth outcomes
- Tracing PFAS Transfer from Mother to the Fetoplacental Unit: Insights from Trimester-Specific Maternal Serum Profiles
- Pfas Exposure During Pregnancy is Associated with Maternal Cardiometabolic and Birth Outcomes
- Tracing PFAS Transfer from Mother to the Fetoplacental Unit: Insights from Trimester-Specific Maternal Serum Profiles
- Tracing PFAS Transfer from Mother to the Fetoplacental Unit: Insights from Trimester-Specific Maternal Serum Profiles
- Tracing PFAS Transfer from Mother to the Fetoplacental Unit: Insights from Trimester-Specific Maternal Serum Profiles
- Tracing PFAS Transfer from Mother to the Fetoplacental Unit: Insights from Trimester-Specific Maternal Serum Profiles
- Tracing PFAS Transfer from Mother to the Fetoplacental Unit: Insights from Trimester-Specific Maternal Serum Profiles
- Tracing PFAS Transfer from Mother to the Fetoplacental Unit: Insights from Trimester-Specific Maternal Serum Profiles
Similar Researchers
Based on overlapping research topics